A Phase II, Randomized, Double-blind, Placebo-controlled study to examine the effects of DAS181 in Immunocompromised subjects with Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
|Effective start/end date||2/1/14 → 12/31/20|
- ANSUN BIOPHARMA, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.